• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Contact us

For Business Enquiries

Request you to provide all details mentioned in the form along with your business requirement. It will help us route your query to the appropriate person.

By submitting this form you agree to our Privacy Policy concerning the way Syngene may use your personal information.

By submitting this form you agree to our Privacy Policy concerning the way Syngene may use your personal information.

*All fields are mandatory

<!-- NOTE: Please add the following element to your page . --> <!-- NOTE: Please add the following element to your page. --> function getUTMParams() { const urlParams = new URLSearchParams(window.location.search); // UTM Fields document.getElementById("00NIS000000SRNB").value = urlParams.get("utm_source") || ""; document.getElementById("00NIS000000SRN7").value = urlParams.get("utm_medium") || ""; document.getElementById("00NIS000000SRN5").value = urlParams.get("utm_campaign") || ""; document.getElementById("00NIS000000SRNC").value = urlParams.get("utm_term") || ""; document.getElementById("00NIS000000SRN6").value = urlParams.get("utm_content") || ""; // GCLID Tracking (Google Ads Click ID) document.getElementById("00NIS000000SRMy").value = urlParams.get("gclid") || ""; // Capture Referral Data document.getElementById("00NIS000000SRN9").value = document.referrer || ""; try { const referrerUrl = new URL(document.referrer); document.getElementById("00NIS000000SRNA").value = referrerUrl.hostname || ""; } catch (e) { document.getElementById("00NIS000000SRNA").value = ""; } // Capture Page URLs document.getElementById("00NIS000000SRN3").value = window.location.href; // Submission Page URL document.getElementById("00NIS000000SRMx").value = sessionStorage.getItem("first_page") || window.location.href; } // Store the first page URL if it's not already set if (!sessionStorage.getItem("first_page")) { sessionStorage.setItem("first_page", window.location.href); } // Run function on page load window.onload = getUTMParams;
<!-- -->
CountryAfghanistan Aland Islands Albania Algeria American Minor Outlying Islands American Samoa American Virgin Islands Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Blue Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Islands Brazil Brit.Virgin Is. British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Islnd Coconut Islands Colombia Comoros Cook Islands Costa Rica Cote d'Ivoire Country Not Available Croatia Cuba Curaçao Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Dutch Antilles East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia European Union Falkland Islands Faroe Islands Fiji Finland France French Guyana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauretania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia NATO Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Islands North Korea North Mariana Islands Norway Oman Orange Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Phillippines Pitcairn Islands Poland Portugal Puerto Rico Qatar Republic of the Congo Reunion Romania Russian Fed. Rwanda Saint Helena Saint Kitts and Nevis Saint Martin (French part) Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Serbia and Montenegro Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the Southern Sandwich Islands South Korea South Sudan Spain Sri Lanka St. Lucia St. Pierre and Miquelon St. Vincent and the Grenadines Sudan Suriname Svalbard Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tokelau Islands Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Kingdom United Nations Uruguay USA Utd.Arab Emir. Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wallis and Futuna Islands West Sahara Yemen Zambia Zimbabwe
















By submitting this form you agree to our Privacy Policy concerning the way Syngene may use your personal information.

*All fields are mandato

For Media Queries:

For Vendor Registrations:

For Investor Relations:

For Quality & Regulatory:

For Media Queries:

For Vendor Registrations:

For Investor Relations:

For Quality & Regulatory:

For Job Seekers

Looking for a rewarding career in Biopharma?

Join our team of dedicated scientists working with global clients to bring innovative treatment/therapies to patients, worldwide.

Corporate Office

Syngene International Ltd.
Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bangalore, Karnataka – 560 099

Mangalore facility

Syngene International Ltd.
MSEZ, IP-38 (Part), IP-39, IP-46, & IP-60, IP-25(Part) & IP-61 (Part)
Kalavar and Bajpe village, Surathkal Hobli, Mangalore taluk, Dakshina Kannada district, Karnataka – 574142

Hyderabad facility

Syngene International Ltd.
Knowledge Square Park -9000, Plot NO.7, Survey No.542, MN Park, Synergy Square 2 Genome Valley, Kolthur Shamirpet, Medchal, Hyderabad, Telangana 500078

U.S. facility

Syngene International Ltd.
5901 E Lombard St, Baltimore, MD 21224, United States

Mangalore facility

Syngene International Ltd.
MSEZ, IP-38 (Part), IP-39, IP-46, & IP-60, IP-25(Part) & IP-61 (Part)
Kalavar and Bajpe village, Surathkal Hobli, Mangalore taluk, Dakshina Kannada district, Karnataka – 574142

Hyderabad facility

Syngene International Ltd.
Knowledge Square Park -9000, Plot NO.7, Survey No.542, MN Park, Synergy Square 2 Genome Valley, Kolthur Shamirpet, Medchal, Hyderabad, Telangana 500078

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details